Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-03-07FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)
FDA approves GLATOPA (glatiramer acetate) under a supplemental application by Sandoz, providing a generic option for multiple sclerosis. The…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Effectiveness of Exergaming in Adittion to Conventional Treatment for Physical Therapy in People with Multiple Sclerosis [NA]
A clinical trial evaluating whether adding exergaming to conventional physical therapy improves outcomes for people with multiple sclerosis;…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis. [NA]
This clinical trial update reports on the frequency of FCGR3A gene polymorphisms in patients with Neuromyelitis Optica Spectrum Disorders, M…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Virtual Reality in Physical Therapy in Multiple Sclerosis [NA]
A completed clinical trial from Charles University evaluates virtual reality-based physical therapy for people with Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Pilates Versus Eccentric Exercises on Multiple Sclerosis [NA]
A completed clinical trial from Cairo University comparing Pilates to eccentric exercises in people with Multiple sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: PET with [18F]Flumazenil As an Index of Neurodegeneration in MS [NA]
The document notes completion of a clinical trial evaluating PET imaging with the radiotracer [18F]Flumazenil as an index of neurodegenerati…
-
FDA approval · 2025-03-03FDA Approved: TIZANIDINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for tizanidine submitted by Apotex Corp. This action approves the changes described in the supplemen…
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Lipoic Acid for Progressive Multiple Sclerosis (MS) [Phase 2]
A Phase 2 trial evaluating alpha-lipoic acid for progressive multiple sclerosis has completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Dubousset Functional Test: an Investigation of Its Validity and Reliability in Individuals with Multiple Sclerosis
A clinical trial evaluating the validity and reliability of the Dubousset Functional Test in individuals with multiple sclerosis; recruitmen…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial [NA]
The FIT4TeleNEURO pragmatic trial evaluating TeleNEURO rehabilitation systems for neurodegenerative conditions is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Relıabılıty and valıdıty of the Two-minute Test wıth Multiple Sclerosis
Ongoing clinical trial from Sanko University evaluating the reliability and validity of a two-minute test in people with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Auditory-motor Coupling in Multiple Sclerosis With Cerebellar Lesions [NA]
Completed clinical trial evaluating auditory-motor coupling in people with multiple sclerosis and cerebellar lesions.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Effect of Variance on Error Correction During Coupling [NA]
A completed Hasselt University clinical trial investigating how variance affects error correction during coupling in the context of Multiple…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects [Phase 1]
A Phase 1 clinical trial assessing the demyelination radiotracer [18F]3F4AP in healthy controls and individuals with Multiple Sclerosis. The…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Exercise Training, Cognition, and Mobility in Older Adults With Multiple Sclerosis [NA]
This clinical trial update describes an ongoing study assessing how exercise training affects cognition and mobility in older adults with mu…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment
A recruiting clinical trial examining the impact of adverse childhood experiences on quality of life and coping strategies in patients with …
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Aerobic Exercise for Urinary Incontinence in Multiple Sclerosis [NA]
A completed clinical trial evaluated aerobic exercise as an intervention for urinary incontinence in people with multiple sclerosis. The stu…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Combined Effects of Balance and Cognitive Training in Patients With Multiple Sclerosis [NA]
This clinical trial update notes a study evaluating the combined effects of balance and cognitive training in patients with Multiple Scleros…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: The Effect of a Mediterranean Diet on Quality of Life in Multiple Sclerosis Patients [NA]
This clinical trial update notes a study evaluating whether a Mediterranean diet improves quality of life in people with Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis [NA]
The trial update indicates the RedCord device is being studied for neurogenic bowel dysfunction in people with multiple sclerosis, with recr…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis [Phase 2]
Biocad completed a Phase 2 comparative trial evaluating the efficacy and safety of BCD-132 against teriflunomide and placebo in multiple scl…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Mechanism of Action of Ocrelizumab in Multiple Sclerosis
A clinical trial update outlines the mechanism of action of ocrelizumab in multiple sclerosis and notes that trial results have been posted …
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Virtual Reality Rehabilitation for Cognitive, Emotional, and Motor Recovery in Neurological Disorders [NA]
A clinical trial update describes a virtual reality rehabilitation program aimed at cognitive, emotional, and motor recovery in neurological…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Advancing Understanding of Transportation Options [NA]
Completed clinical trial update from University of Colorado, Denver examining transportation options across multiple conditions; results pos…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Effect of Motor Cognitive Interference on Cognition and Quality of Life on Patients with Multiple Sclerosis [NA]
A Cairo University-led clinical trial is evaluating how motor cognitive interference affects cognition and quality of life in people with Mu…